XOMA Royalty (XOMA) Other Operating Expenses (2011 - 2026)

XOMA Royalty's (XOMA) quarterly Other Operating Expenses came in at $27000.0 in Q1 2026, up 100.42% year-on-year from $13472.0 in Q1 2025, and up 100.27% quarter-over-quarter from -$10.1 million in Q4 2025.

XOMA Royalty (XOMA) Other Operating Expenses (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed Other Operating Expenses across 14 years of filings, most recently posting $27000.0 for Q1 2026.

  • Other Operating Expenses for Q1 2026 came in at $27000.0, up 100.42% year-over-year; the trailing twelve-month figure through Mar 2026 was -$19.9 million (down 2342.44% YoY), and the FY2025 annual result was -$26.5 million, down 6569.27% from the prior year.
  • Other Operating Expenses came in at $27000.0 for Q1 2026 at XOMA Royalty, up from -$10.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $7.0 million in Q3 2024 to a low of -$10.1 million in Q4 2025.
  • The 5-year median for Other Operating Expenses is -$618000.0 (2024), against an average of -$2.0 million.
  • Across the five-year window, Other Operating Expenses slumped 3236.89% in 2024 and jumped 100.42% in 2026, its largest moves.
  • XOMA Royalty's Other Operating Expenses stood at $97000.0 in 2022, then surged by 1754.64% to $1.8 million in 2023, then decreased by 8.73% to $1.6 million in 2024, then tumbled by 714.13% to -$10.1 million in 2025, then jumped by 100.27% to $27000.0 in 2026.
  • The last three Other Operating Expenses figures came in at $27000.0 (Q1 2026), -$10.1 million (Q4 2025), and -$4.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 XOMA Royalty 5.52 Mn -60.56 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 27,000.00
Dec 31, 2025 -10.08 Mn
Sep 30, 2025 -4.48 Mn
Jun 30, 2025 -5.33 Mn
Mar 31, 2025 -6.50 Mn
Dec 31, 2024 1.64 Mn
Sep 30, 2024 7.01 Mn
Jun 30, 2024 -1.26 Mn
Mar 31, 2024 -7.06 Mn
Jun 30, 2023 1.80 Mn
Mar 31, 2023 225,000.00
Dec 31, 2022 97,000.00
Dec 31, 2020 -1,000.00
Dec 31, 2018 -543,000.00
Dec 31, 2017 -1,000.00
Jun 30, 2017 -1.46 Mn
Mar 31, 2017 -2.02 Mn
Dec 31, 2016 -4.55 Mn
Jun 30, 2016 21,000.00
Mar 31, 2016 -36,000.00